The value of reverse transcription-polymerase chain reaction in malignant melanoma

British Journal of Dermatology

Volumn 145, Issue 2, 2001, Pages 193-194

  Russell Jones, R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ANALYTIC METHOD; ANTIGEN EXPRESSION; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; NEVUS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SHORT SURVEY;

HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0034788548     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04332.x     Document Type: Short Survey

References (9)

1. A new American Joint Committee on cancer staging system for cutaneous melanoma
2. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel node status in 612 stage I or II melanoma patients
3. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: Association with Breslow's tumour thickness
4. Sentinel lymph node biopsy for melanoma. Experience with 234 consecutive procedures
5. Evaluation of the use of tyrosinase-specific and MelanA/MART-1-specific reverse transcriptase-coupled-polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma
6. The argument against sentinel node biopsy for malignant melanoma
7. Molecular staging of malignant melanoma
8. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma
9. Long-term follow-up of melanoma patients with sentinel node micrometastases detected by nested RT-PCR for tyrosinase